Fecal microbial transplant effect on clinical outcomes and fecal microbiome in active Crohn's disease

Inflammatory Bowel Diseases

Volumn 21, Issue 3, 2015, Pages 556-563

  Suskind, David L ^a   Brittnacher, Mitchell J ^b   Wahbeh, Ghassan ^a   Shaffer, Michele L ^a   Hayden, Hillary S ^b   Qin, Xuan ^b   Singh, Namita ^c   Damman, Christopher J ^b   Hager, Kyle R ^b   Nielson, Heather ^a   Miller, Samuel I ^b  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

Crohn's disease; fecal microbial transplant; fecal microbiome; FMT; inflammatory bowel disease; pediatrics

Indexed keywords

AZATHIOPRINE; C REACTIVE PROTEIN; CALGRANULIN; FOLIC ACID; IMMUNOMODULATING AGENT; INFLIXIMAB; MERCAPTOPURINE; MESALAZINE; METHOTREXATE; METRONIDAZOLE; PREDNISONE;

ABDOMINAL PAIN; ADOLESCENT; ADULT; ALLERGIC REACTION; ARTICLE; BLOATING; CHILD; CLINICAL ARTICLE; CLINICAL EVALUATION; CROHN DISEASE; DIARRHEA; ENGRAFTMENT; FECAL MICROBIAL TRANSPLANTATION; FECES; FECES MICROFLORA; FEMALE; FOLLOW UP; HUMAN; MALE; METAGENOMICS; MICROBIOME; NASOGASTRIC TUBE; OPEN STUDY; PEDIATRIC CROHN'S DISEASE ACTIVITY INDEX; PRIORITY JOURNAL; RATING SCALE; REMISSION; RHINORRHEA; SCHOOL CHILD; SCORING SYSTEM; SORE THROAT; TRANSPLANTATION; TREATMENT OUTCOME; YOUNG ADULT; BIOLOGICAL THERAPY; BIOLOGY; CLINICAL TRIAL; METAGENOME; MICROBIOLOGY; MICROFLORA; PATHOPHYSIOLOGY; PROGNOSIS;

ADOLESCENT; ADULT; BIOLOGICAL THERAPY; CHILD; COMPUTATIONAL BIOLOGY; CROHN DISEASE; FECES; FEMALE; HUMANS; MALE; METAGENOME; MICROBIOTA; PROGNOSIS; YOUNG ADULT;

EID: 84923436937     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1097/MIB.0000000000000307     Document Type: Article

References (17)

1. Frank DN, St Amand AL, Feldman RA, et al. Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases. Proc Natl Acad Sci U S A. 2007; 104: 13780-13785.
2. Fujimoto T, Imaeda H, Takahashi K, et al. Decreased abundance of Faecalibacterium prausnitzii in the gut microbiota of Crohn's disease. J Gastroenterol Hepatol. 2013; 28: 613-619.
3. Eiseman B, Silen W, Bascom GS, et al. Fecal enema as an adjunct in the treatment of pseudomembranous enterocolitis. Surgery. 1958; 44: 854-859.
4. Bakken JS, Borody T, Brandt LJ, et al. Treating Clostridium difficile infection with fecal microbiota transplantation. Clin Gastroenterol Hepatol. 2011; 9: 1044-1049.
5. Hyams J, Markowitz J, Otley A, et al. Evaluation of the pediatric crohn disease activity index: a prospective multicenter experience. J Pediatr Gastroenterol Nutr. 2005; 41: 416-421.
6. Maillet N, Lemaitre C, Chikhi R, et al. Compareads: comparing huge metagenomic experiments. BMC Bioinformatics. 2012; 13(suppl 19): S10.
7. Segata N, Waldron L, Ballarini A, et al. Metagenomic microbial community profiling using unique clade-specific marker genes. Nat Methods. 2012; 9: 811-814.
8. Borody TJ, George L, Andrews P, et al. Bowel-flora alteration: a potential cure for inflammatory bowel disease and irritable bowel syndrome. Med J Aust. 1989; 150: 604.
9. Grehan MJ, Borody TJ, Leis SM, et al. Durable alteration of the colonic microbiota by the administration of donor fecal flora. J Clin Gastroenterol. 2010; 44: 551-561.
10. Zholudev A, Zurakowski D, Young W, et al. Serologic testing with ANCA, ASCA, and anti-OmpC in children and young adults with Crohn's disease and ulcerative colitis: diagnostic value and correlation with disease phenotype. Am J Gastroenterol. 2004; 99: 2235-2241.
11. Sartor RB. Therapeutic manipulation of the enteric microflora in inflammatory bowel diseases: antibiotics, probiotics, and prebiotics. Gastroenterology. 2004; 126: 1620-1633.
12. Winslet MC, Andrews H, Allan RN, et al. Fecal diversion in the management of Crohn's disease of the colon. Dis Colon Rectum. 1993; 36: 757-762.
13. Kronman MP, Zaoutis TE, Haynes K, et al. Antibiotic exposure and IBD development among children: a population-based cohort study. Pediatrics. 2012; 130: e794-803.
14. Shaw SY, Blanchard JF, Bernstein CN. Association between the use of antibiotics and new diagnoses of Crohn's disease and ulcerative colitis. Am J Gastroenterol. 2011; 106: 2133-2142.
15. Virta L, Auvinen A, Helenius H, et al. Association of repeated exposure to antibiotics with the development of pediatric Crohn's disease-A nationwide, register-based finnish case-control study. Am J Epidemiol. 2012; 175: 775-784.
16. Wang W, Chen L, Zhou R, et al. Increased proportions of bifidobacterium and the lactobacillus group and loss of butyrate-producing bacteria in inflammatory bowel disease. J Clin Microbiol. 2014; 52: 398-406.
17. Kleessen B, Kroesen AJ, Buhr HJ, et al. Mucosal and invading bacteria in patients with inflammatory bowel disease compared with controls. Scand J Gastroenterol. 2002; 37: 1034-1041.